| Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 |
---|
Goods | - | - | 156 | 176 | 204 | 266 | 314 | 389 |
---|
Commercialization Services | - | - | 12 | 3 | 4 | 27 | 41 | 49 |
---|
License & Collaborations-Services | - | - | 18 | 16 | 10 | 19 | 24 | 80 |
---|
Services-Research and Development | - | - | 8 | 0 | 0 | 1 | 1 | 34 |
---|
Other collaboration revenue-royalties | - | - | 0 | 3 | 5 | 15 | 26 | 32 |
---|
Other collaboration revenue-licensing | - | - | 12 | - | - | 24 | 15 | 279 |
---|
Services-commercialization | - | - | 12 | 3 | 4 | 27 | 41 | 49 |
---|
Services-research and development | - | - | 8 | 0 | 0 | 1 | 1 | 34 |
---|
Services-collaboration research and development | - | - | 18 | 16 | 10 | 19 | 24 | 80 |
---|
Other collaboration revenue-royalties | - | - | 0 | 3 | 5 | 15 | 26 | 32 |
---|
Other collaboration revenue-licensing | - | - | 12 | - | - | 24 | 15 | 279 |
---|
Revenue | 216 | 241 | 214 | 205 | 228 | 356 | 426 | 838 |
---|
Goods | - | - | 129 | 153 | 179 | 229 | 269 | 332 |
---|
Commercialization Services | - | - | 9 | 2 | 6 | 26 | 39 | 48 |
---|
Services-commercialization | - | - | 9 | 2 | 6 | 26 | 39 | 48 |
---|
Research and development expenses | 67 | 76 | 114 | 138 | 175 | 299 | 387 | 302 |
---|
Selling expenses | 18 | 19 | 18 | 14 | 11 | 38 | 44 | 53 |
---|
Administrative expenses | 22 | 24 | 31 | 39 | 50 | 89 | 92 | 80 |
---|
Total operating expenses | - | 295 | 307 | 351 | 425 | 684 | 834 | 820 |
---|
Income/(Loss) from operations | -47 | -53 | -93 | -146 | -197 | -328 | -408 | 18 |
---|
Gain on divestment of an equity investee | - | - | - | - | - | 121 | - | - |
---|
Interest income | 1 | 1 | 6 | 5 | 3 | 2 | 10 | 36 |
---|
Other income | 1 | 1 | 2 | 2 | 5 | 2 | 2 | 13 |
---|
Interest expense | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
---|
Other expense | - | 1 | 1 | 0 | 0 | 13 | 14 | 8 |
---|
Total other income/(expense) | -1 | -0 | 6 | 5 | 7 | -9 | -3 | 40 |
---|
Income/(loss) before income taxes and equity in earnings of equity investees | -47 | -54 | -87 | -141 | -190 | -216 | -410 | 58 |
---|
Income tax (expense)/benefit | 4 | 3 | 4 | 3 | 5 | 12 | -0 | 5 |
---|
Income (Loss) from Equity Method Investments | 66 | 34 | 19 | 41 | 79 | 61 | 50 | 47 |
---|
Net income/(loss) | 15 | -23 | -71 | -104 | -116 | -167 | -360 | 101 |
---|
Less: Net income attributable to non-controlling interests | 3 | 4 | 4 | 2 | 10 | 28 | 0 | 0 |
---|
Net income/(loss) attributable to the Company | 15 | -23 | -71 | -104 | -116 | -167 | -360 | 101 |
---|
Earnings Per Share, Basic | - | -0.43 | -1.13 | - | - | -0.25 | -0.43 | 0.12 |
---|
Earnings Per Share, Diluted | - | -0.43 | -1.13 | - | - | -0.25 | -0.43 | 0.12 |
---|